Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen

  1. Fleeman, N.
  2. Payne, K.
  3. Newman, W.G.
  4. Howell, S.J.
  5. Boland, A.
  6. Oyee, J.
  7. Saborido, C.M.
  8. Santander, A.F.
  9. Dickson, R.
Revista:
Personalized Medicine

ISSN: 1741-0541 1744-828X

Any de publicació: 2013

Volum: 10

Número: 6

Pàgines: 601-611

Tipus: Article

DOI: 10.2217/PME.13.60 GOOGLE SCHOLAR